IS NICOTINE REPLACEMENT THERAPY GIVEN DURING GESTATION CONSIDERED SAFE FOR OFFSPRING NEURODEVELOPMENT IN A RAT MODEL?
| dc.contributor.author | Tabet, Dana | |
| dc.contributor.supervisor | Konkle, Anne | |
| dc.date.accessioned | 2018-05-15T00:10:42Z | |
| dc.date.available | 2018-05-15T00:10:42Z | |
| dc.date.issued | 2018 | |
| dc.identifier.uri | http://hdl.handle.net/10393/37694 | |
| dc.identifier.uri | https://doi.org/10.20381/ruor-21958 | |
| dc.language.iso | en | en_US |
| dc.title | IS NICOTINE REPLACEMENT THERAPY GIVEN DURING GESTATION CONSIDERED SAFE FOR OFFSPRING NEURODEVELOPMENT IN A RAT MODEL? | en_US |
| dc.type | Poster | en_US |
